X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (797) 797
index medicus (788) 788
male (472) 472
female (465) 465
adult (306) 306
retroperitoneal neoplasms - pathology (291) 291
middle aged (271) 271
oncology (245) 245
surgery (215) 215
retroperitoneal neoplasms - genetics (210) 210
aged (207) 207
tumors (166) 166
pathology (156) 156
retroperitoneal neoplasms - surgery (153) 153
cancer (152) 152
retroperitoneal neoplasms - diagnosis (141) 141
prognosis (135) 135
medicine & public health (105) 105
abridged index medicus (103) 103
diagnosis, differential (103) 103
sarcoma (98) 98
treatment outcome (97) 97
immunohistochemistry (91) 91
adolescent (89) 89
diagnosis (88) 88
infant (87) 87
chemotherapy (84) 84
child, preschool (84) 84
child (83) 83
tomography, x-ray computed (83) 83
neoplasm staging (76) 76
retrospective studies (76) 76
care and treatment (69) 69
follow-up studies (69) 69
liposarcoma (67) 67
liposarcoma - pathology (67) 67
aged, 80 and over (65) 65
metastasis (64) 64
pediatrics (63) 63
retroperitoneal neoplasms - therapy (59) 59
retroperitoneal space (59) 59
survival (55) 55
liposarcoma - genetics (54) 54
magnetic resonance imaging (53) 53
analysis (52) 52
management (52) 52
retroperitoneum (52) 52
health aspects (51) 51
karyotyping (51) 51
research (51) 51
case report (50) 50
combined modality therapy (50) 50
risk factors (50) 50
urology & nephrology (50) 50
retroperitoneal neoplasms - metabolism (49) 49
retroperitoneal neoplasms - complications (47) 47
retroperitoneal neoplasms - secondary (47) 47
young adult (47) 47
testicular neoplasms - pathology (46) 46
animals (45) 45
biopsy (45) 45
lymphatic metastasis (43) 43
neuroblastoma (42) 42
retroperitoneal neoplasms - drug therapy (42) 42
survival rate (42) 42
neoplasms (41) 41
neuroblastoma - genetics (41) 41
retroperitoneal neoplasms - diagnostic imaging (40) 40
gene amplification (39) 39
radiotherapy (39) 39
sarcoma - pathology (39) 39
abdomen (38) 38
carcinoma (38) 38
expression (38) 38
patients (38) 38
prognostic-factors (38) 38
retroperitoneal neoplasms - mortality (38) 38
soft-tissue sarcoma (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (37) 37
biomarkers, tumor - analysis (37) 37
genetics & heredity (37) 37
mutation (37) 37
obstetrics & gynecology (37) 37
children (36) 36
fatal outcome (36) 36
retroperitoneal (36) 36
in situ hybridization, fluorescence (35) 35
neuroblastoma - pathology (35) 35
hematology (34) 34
soft tissue neoplasms - pathology (33) 33
adrenal gland neoplasms - genetics (32) 32
sarcoma - surgery (32) 32
antineoplastic agents - therapeutic use (31) 31
chromosome aberrations (31) 31
dedifferentiated liposarcoma (31) 31
infant, newborn (31) 31
medicine, general & internal (31) 31
mdm2 (30) 30
paraganglioma (30) 30
recurrence (30) 30
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (825) 825
German (13) 13
Chinese (9) 9
French (7) 7
Japanese (6) 6
Italian (4) 4
Spanish (3) 3
Dutch (1) 1
Hungarian (1) 1
Polish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Pathology, ISSN 0893-3952, 12/2011, Volume 24, Issue 12, pp. 1560 - 1570
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2013, Volume 132, Issue 7, pp. 1711 - 1717
Perivascular epithelioid cell tumors (PEComas) are a group of rare mesenchymal tumors that typically show both melanocytic and smooth muscle cell features.... 
mTOR | TSC2 | perivascular epithelioid cell tumor | everolimus | PEComa | sirolimus | MAMMALIAN TARGET | RAPAMYCIN | ACTIVATION | LYMPHANGIOLEIOMYOMATOSIS | TUBEROUS SCLEROSIS COMPLEX | GENE | ONCOLOGY | ANGIOMYOLIPOMA | PATHWAY | Adrenal Gland Neoplasms - drug therapy | Prognosis | TOR Serine-Threonine Kinases - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Loss of Heterozygosity | Immunoenzyme Techniques | TOR Serine-Threonine Kinases - antagonists & inhibitors | Perivascular Epithelioid Cell Neoplasms - drug therapy | Retroperitoneal Neoplasms - drug therapy | TOR Serine-Threonine Kinases - genetics | Review Literature as Topic | Retroperitoneal Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Adult | Female | Retroperitoneal Neoplasms - pathology | Everolimus | Adrenal Gland Neoplasms - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | In Situ Hybridization, Fluorescence | Mutation - genetics | Remission Induction | Perivascular Epithelioid Cell Neoplasms - pathology | Antibiotics, Antineoplastic - therapeutic use | Perivascular Epithelioid Cell Neoplasms - genetics | Aged | Adrenal Gland Neoplasms - genetics | Tuberous sclerosis | Sarcoma | Genes | Melanoma | Stem cells | Cancer | Medical research | Chemotherapy | Muscular system | Tumors | Index Medicus
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 08/2017, Volume 125, Issue 8, pp. 604 - 614
The presence of pleomorphic and epithelioid large cells with binucleation and/or multinucleation in an inflammatory background, especially in patients with a... 
epithelioid | KMT2D | MLL2 | CD163 | mixed‐lineage leukemia 2 | lysine methyltransferase 2D | ) | PU.1 | histiocytic sarcoma | transdifferentiation | immunohistochemistry | fine‐needle aspiration | next‐generation sequencing | next-generation sequencing | lysine methyltransferase 2D (KMT2D)/mixed-lineage leukemia 2 (MLL2) | fine-needle aspiration | NEOPLASMS | FOLLICULAR LYMPHOMA | CYTOLOGY | PATHOLOGY | CANCER | FINE-NEEDLE-ASPIRATION | DENDRITIC CELL-DIFFERENTIATION | ONCOLOGY | MUTATIONS | SEQUENCING DATA | EXPRESSION | Immunohistochemistry | Uterine Neoplasms - pathology | Epigenesis, Genetic | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Bone Neoplasms - pathology | Antigens, CD - metabolism | Histiocytic Sarcoma - metabolism | Retroperitoneal Neoplasms - genetics | Aged, 80 and over | Liver Neoplasms - pathology | Bone Neoplasms - genetics | Liver Neoplasms - secondary | Neoplasm Proteins - genetics | Retroperitoneal Neoplasms - pathology | Uterine Neoplasms - genetics | Scapula - metabolism | Sequence Analysis, DNA | Retroperitoneal Neoplasms - metabolism | Scapula - pathology | Liver Neoplasms - metabolism | Soft Tissue Neoplasms - pathology | Lung Neoplasms - surgery | Scapula - surgery | Lung Neoplasms - pathology | Bone Neoplasms - metabolism | Soft Tissue Neoplasms - surgery | Female | Histiocytic Sarcoma - genetics | Histiocytic Sarcoma - pathology | Neck | Retroperitoneal Neoplasms - surgery | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Uterine Neoplasms - metabolism | Soft Tissue Neoplasms - secondary | Soft Tissue Neoplasms - metabolism | Receptors, Cell Surface - metabolism | Liver Neoplasms - surgery | Bone Neoplasms - surgery | DNA-Binding Proteins - genetics | Histiocytic Sarcoma - surgery | Uterine Neoplasms - surgery | Antigens, Differentiation, Myelomonocytic - metabolism | Trans-Activators - metabolism | Aged | High-Throughput Nucleotide Sequencing | Sarcoma | Oncology, Experimental | Molecular diagnostic techniques | Biopsy, Needle | Diagnosis | Research | Methods | Cancer | Pathogenesis | Leukemia | Lymphomas | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 08/2014, Volume 7, Issue 1, pp. 52 - 52
Background: Germ cell tumors (GCT) are the most common solid tumors in adolescent and young adult males (age 15 and 35 years) and remain one of the most... 
Adolescent and young adult | RET | Outlier responder | Targeted therapy | VEGF | Unusual responder | Phase II trials | Vascular endothelial growth factor receptor | Next generation sequencing | EGFR | Exceptional responder | Germ cell tumor | Sunitinib | COMPLETE RESPONSE | TESTICULAR CANCER | LATE RELAPSE | AMPLIFICATION | TYROSINE KINASE INHIBITOR | HEMATOLOGY | ENDOTHELIAL GROWTH-FACTOR | SOLID TUMORS | ONCOLOGY | THYROID-CARCINOMA | PATHWAY CONTRIBUTES | IMATINIB MESYLATE | Testicular Neoplasms - mortality | Mediastinal Neoplasms - genetics | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Antineoplastic Agents - therapeutic use | Neoplasms, Germ Cell and Embryonal - genetics | Platinum Compounds - therapeutic use | Young Adult | Retroperitoneal Neoplasms - mortality | Mediastinal Neoplasms - drug therapy | Retroperitoneal Neoplasms - drug therapy | Retroperitoneal Neoplasms - genetics | Adult | Neoplasms, Germ Cell and Embryonal - drug therapy | Pyrroles - therapeutic use | Neoplasms, Germ Cell and Embryonal - mortality | Testicular Neoplasms - genetics | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Testicular Neoplasms - drug therapy | Protein Kinase Inhibitors - therapeutic use | Adolescent | Indoles - therapeutic use | High-Throughput Nucleotide Sequencing | Proto-Oncogene Proteins c-ret - genetics | Index Medicus
Journal Article
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 03/2015, Volume 39, Issue 3, pp. 383 - 393
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 05/2017, Volume 41, Issue 5, pp. 577 - 585
Most gastrointestinal stromal tumors (GISTs) occur in the tubular gastrointestinal (GI) tract, but some present apparently outside the GI tract. In this study,... 
PDGFRA | Prognosis | Mutation | SDHB | KIT | Gastrointestinal stromal tumor | SURGERY | CELLS | PANCREAS REPORT | C-KIT | PATHOLOGY | SOFT-TISSUE | prognosis | mutation | AMPLIFICATION | gastrointestinal stromal tumor | MUTATIONS | EXPRESSION | STOMACH | Immunohistochemistry | Multivariate Analysis | Predictive Value of Tests | Anoctamin-1 | Humans | Middle Aged | Male | Retroperitoneal Neoplasms - diagnosis | Retroperitoneal Neoplasms - chemistry | Young Adult | Molecular Diagnostic Techniques | Gastrointestinal Stromal Tumors - diagnosis | Time Factors | DNA Mutational Analysis | Gastrointestinal Stromal Tumors - pathology | Retroperitoneal Neoplasms - genetics | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-kit - genetics | Succinate Dehydrogenase - analysis | Retroperitoneal Neoplasms - pathology | Gastrointestinal Stromal Tumors - genetics | Chloride Channels - analysis | Genetic Predisposition to Disease | Biomarkers, Tumor - analysis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Tumor Burden | Proto-Oncogene Proteins c-kit - analysis | Mitotic Index | Phenotype | Biopsy | Gastrointestinal Stromal Tumors - chemistry | Receptor, Platelet-Derived Growth Factor alpha - genetics | Neoplasm Proteins - analysis | Aged | Biomarkers, Tumor - genetics | Index Medicus
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2010, Volume 127, Issue 5, pp. 1052 - 1059
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 06/2014, Volume 61, Issue 6, pp. 1104 - 1106
Patients <12 months with favorable biology, metastatic neuroblastoma have >90% overall survival following treatment with chemotherapy and surgery. We report... 
intermediate‐risk neuroblastoma | neuroblastoma | refractory disease | Intermediate-risk neuroblastoma | Refractory disease | Neuroblastoma | intermediate-risk neuroblastoma | CHROMOSOME 1P | CHEMOTHERAPY | CHILDREN | ONCOLOGY | TUMOR-CELL PLOIDY | TOPOTECAN | INFANTS | PEDIATRIC-ONCOLOGY-GROUP | PEDIATRICS | HEMATOLOGY | Adrenal Gland Neoplasms - surgery | Abdominal Neoplasms - secondary | Isotretinoin - therapeutic use | Prognosis | Humans | Salvage Therapy | Infant | Male | Risk | Antineoplastic Agents - therapeutic use | Biomarkers, Tumor | Neuroblastoma - secondary | Retroperitoneal Neoplasms - drug therapy | Retroperitoneal Neoplasms - genetics | Orbital Neoplasms - genetics | Female | Retroperitoneal Neoplasms - surgery | Abdominal Neoplasms - drug therapy | Neuroblastoma - genetics | Orbital Neoplasms - drug therapy | Treatment Outcome | Combined Modality Therapy | Lymphatic Metastasis | Abdominal Neoplasms - surgery | Disease Progression | Orbital Neoplasms - secondary | Thoracic Neoplasms - genetics | Thoracic Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroblastoma - drug therapy | Abdominal Neoplasms - genetics | Neuroblastoma - surgery | Watchful Waiting | Thoracic Neoplasms - drug therapy | Adrenal Gland Neoplasms - genetics | Development and progression | Care and treatment | Chemotherapy | Metastasis | Cancer | Index Medicus
Journal Article
Histopathology, ISSN 0309-0167, 01/2013, Volume 62, Issue 2, pp. 287 - 293
Aims:  Occasional cases of well‐differentiated and dedifferentiated liposarcoma (LPS) contain myxoid stroma, leading to confusion with other sarcomas. The aim... 
dedifferentiated liposarcoma | well‐differentiated liposarcoma | fluorescence | in‐situ | MDM2 | cytogenetics | hybridization | Cytogenetics | Dedifferentiated liposarcoma | Fluorescence in-situ hybridization | Well-differentiated liposarcoma | SUBTYPES | CELL LIPOSARCOMA | well-differentiated liposarcoma | fluorescence in-situ hybridization | CHROMOSOMES | PATHOLOGY | MOLECULAR ANALYSIS | FEATURES | CELL BIOLOGY | CHOP | Liposarcoma, Myxoid - metabolism | Stromal Cells - pathology | Humans | Middle Aged | Liposarcoma, Myxoid - pathology | Male | Young Adult | Abdominal Neoplasms - metabolism | Retroperitoneal Space | Mucins - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | DNA, Neoplasm - analysis | Liposarcoma, Myxoid - genetics | Proto-Oncogene Proteins c-mdm2 - metabolism | Soft Tissue Neoplasms - genetics | Stromal Cells - metabolism | Soft Tissue Neoplasms - metabolism | In Situ Hybridization, Fluorescence | Cyclin-Dependent Kinase 4 - metabolism | Adipocytes - pathology | Gene Amplification | Adipocytes - metabolism | Abdominal Neoplasms - genetics | Adolescent | Chromosome Aberrations | Soft Tissue Neoplasms - pathology | Abdominal Neoplasms - pathology | Aged | Chromosomes, Human, Pair 12 | Immunohistochemistry | Sarcoma | Analysis | Fluorescence | Metastasis | Chromosomes | Medical diagnosis | Medical treatment | Index Medicus
Journal Article